Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88

Journal of Clinical Investigation

Volumn 114, Issue 12, 2004, Pages 1790-1799

  Fremond, Cecile M ^a   Yeremeev, Vladimir ^a,c   Nicolle, Delphine M ^a   Jacobs, Muazzam ^b   Quesniaux, Valerie F ^a   Ryffel, Bernhard ^a  

^a CNRS   (France)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c CENTRAL TUBERCULOSIS RESEARCH INSTITUTE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD40 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 12; MYCOBACTERIUM ANTIGEN; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; CYTOKINE; DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN RECEPTOR; MYD88 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FATALITY; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION CONTROL; LOBAR PNEUMONIA; MACROPHAGE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VACCINATION; ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SEPARATION; CROSS BREEDING; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; PNEUMONIA; TIME; TRANSGENE; TRANSGENIC MOUSE; TUBERCULOSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; CROSSES, GENETIC; CYTOKINES; DENDRITIC CELLS; FLOW CYTOMETRY; INTERFERON TYPE II; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; PNEUMONIA; RECEPTORS, IMMUNOLOGIC; TIME FACTORS; TRANSGENES; TUBERCULOSIS;

EID: 14044253038     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200421027     Document Type: Article

References (49)

1. Dye, C., Williams, B.C., Espinal, M.A., and Raviglione, M.C. 2002. Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science. 295:2042-2046.
2. Flynn, J.L., and Chan, J. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129.
3. Akira, S. 2003. Mammalian Toll-like receptors. Curr. Opin. Immunol. 15:5-11.
4. Aliprantis, A.O., et al. 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science. 285:736-739.
5. Thoma-Uszynski,S.,et al. 2001. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science. 291:1544-1547.
6. Underbill, D.M., Ozinsky, A., Smith, K.D., and Adercm, A. 1999. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. U. S. A. 96:14459-14463.
7. Gilleron, M., Quesniaux, V.F., and Puxo, G. 2003. Acylation state of the phosphatidylinositol hexamannosides from mycobacterium bovis BCG and mycobacterium tuberculosis H37Rv and its implication in TLR response. J. Biol. Chem. 278:29880-29889.
8. Guerardel, Y., et al. 2003. Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii: novel structural features and apoptosis-inducing properties. J. Biol. Chem. 278:36637-36651.
9. Quesniaux, V.J., et al. 2004. Toll-like receptor 2 (TLR2)-dependent- positivc and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J. Immunol. 172:4425-4434.
10. Abel, B., et al. 2002. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol. 169:3155-3162.
11. Reiling, N., et al. 2002. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol. 169:3480-3484.
12. Sugawara, I., et al. 2003. Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol. Immunol. 47:327-336.
13. Heldwein, K.A., et al. 2003. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG. J. Leukoc. Biol. 74:277-286.
14. Drennan, M.B., et al. 2004. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am. J. Pathol. 164:49-57.
15. Kawai, T., Adachi, O., Ogawa, T., Takeda, K., and Akira, S. 1999. Unresponsiveness of MyD88-deficient mice to endotoxm. Immunity. 11:115-122.
16. Takeuchi, O., Hoshino, K., and Akira, S. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392-5396.
17. Muraille, E., et al. 2003. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J. Immunol. 170:4237-4241.
18. Schnare, M., et al. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2:947-950.
19. Mun, H.S., et al. 2003. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int. Immunol. 15:1081-1087.
20. Scanga, C.A., et al. 2002. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168:5997-6001.
21. Feng, G.G., et al. 2003. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J. Immunol. 171:4758-4764.
22. Flynn, J.L., et al. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 2:561-572.
23. Jacobs, M., et al. 2000. Correction of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation. Lab. Invest. 80:901-914.
24. Nicolle, D., et al. 2004. Chronic pneumonia despite adaptive immune response to Mycobacterium bovis BCG in MyD88-deficient mice. Lab. Invest. 84:1305-1321.
25. Way, S.S., Kollmann, T.R., Hajjar, A.M., and Wilson, C.B. 2003. Protective cell-mediated immunity to Listeria monocytogenes in the absence of myeloid differentiation factor 88. J. Immunol. 171:533-537.
26. Netea, M.G., et al. 2002. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J. Infect. Dis. 185:1483-1489.
27. Chen, M., et al. 2002. Involvement of MyD88 in host defense and the down-regulation of antiheat shock protein 70 autoantibody formation by MyD88 in Toxoplasma gondii-infected mice. J. Parasitol. 88:1017-1019.
28. Fremond, C.M., Nicolle, D.M., Torres, D.S., and Quesniaux, V.F. 2003. Control of Mycobacterium bovis BCG infection with increased inflammation in TLR4-deficient mice. Microbes Infect. 5:1070-1081.
29. Nicolle, D., et al. 2005. Long-term control of Mycobacterium bovis BCG infection in the absence of Toll-like receptors: investigation on TLR2, TLR6 or TLR2-TLR4 deficient mice. Infect. Immun. In press.
30. Hoebe, K., et al. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature. 424:743-748.
31. Shi, S., et al. 2003. MyD88 primes macrophages for full-scale activation by mterferon-{gamma} yet mediates few responses to Mycobacterium tuberculosis. J. Exp. Med. 198:987-997.
32. Ladel, C.H., et al. 1997. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect. Immun. 65:4843-4849.
33. Saunders, B.M., Frank, A.A., Orme, I.M., and Cooper, A.M. 2000. Interleukin-6 induces early gamma Interferon production in the infected king but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect. Immun. 68:3322-3326.
34. Sugawara, I., et al. 1999. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect. Immun. 67:2585-2589.
35. Juffermans, N.P., et al. 2000. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J. Infect. Dis. 182:902-908.
36. Yamada, H., Mizumo, S., Horai, R., Iwakura, Y., and Sugawara, I. 2000. Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double-knockout mice. Lab. Invest. 80:759-767.
37. Glaccum, M.B., et al. 1997. Phenotypic and functional characterisation of mice that lack the type I receptor for IL-1. J. Immunol. 159:3364-3371.
38. Gomes, M.S., Florido, M., Pais, T.F., and Appelberg, R. 1999. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthasc gene. J. Immunol. 162:6734-6739.
39. MacMicking, J.D., et al. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 94:5243-5248.
40. Sugawara, I., Yamada, H., Mizuno, S., Takeda, K., and Akira, S. 2003. Mycobacterial infection in MyD88-deficient mice. Microbiol. Immunol. 47:841-847.
41. Scanga, C.A., et al. 2004. MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect. Immun. 72:2400-2404.
42. Marino, M.W., et al. 1997. Characterisation of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 94:8093-8098.
43. Yeremeev, V.V., et al. 2003. Proteins of the Rpf family: immune cell reactivity and vaccination efficacy against tuberculosis in mice. Infect. Immun. 71:4789-4794.
44. Jacobs, M., Brown, N., Allie, N., and Ryffel, B. 2000. Fatal Mycobacterium bovis BCG infection in TNF-LT-alpha-deficient mice. Clin. Immunol. 94:192-199.
45. Botha, T., and Ryffel, B. 2003. Reactivation of latent tuberculosis infection in TNF-deficient mice. J. Immunol. 171:3110-3118.
46. Lyadova, I.V., et al. 2000. Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease. J. Immunol. 165:5921-5931.
47. Muller, M., et al. 1996. Correction or transfer of immunodeficiency due to TNF-LT alpha deletion by bone marrow transplantation. Mol. Meet. 2:247-255.
48. Lutz, M.B., et al. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 223:77-92.
49. Green, L.C., et al. 1982. Analysis of nitrate, nitrite, and [15N]nitratein biological fluids. Anal. Biochem. 126:131-138.